Akebia Therapeutics: Q4 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $7.6 million in its fourth quarter. ...
March 16, 2023
1:26 AM
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $7.6 million in its fourth quarter. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 4 cents. The kidney disease treatment developer posted revenue of $55.2 million in the period. For the year, the company reported that its loss narrowed to $92.6 million, or 51 cents per share. Revenue was reported as $292.6 million. The company's shares closed at $1.
Ariana Garcia